Panda Surgical

Country:
UK
Founding year:
2022

Panda Surgical is developing a handheld robotics platform for minimally invasive neurosurgery. The company is a University College London spinout and focuses on procedures where narrow anatomical corridors limit instrument dexterity, particularly in cranial and spinal workflows. Its system is designed to give surgeons greater control in confined spaces while keeping the interaction closer to familiar handheld surgical tools.

The platform uses detachable wristed instruments as small as 3 mm in diameter, controlled through a handheld robotic device. Public materials also describe AI-powered software intended to support intraoperative workflow and decision-making. Panda has completed preclinical in-vivo work in endoscopic brain surgery and has secured U.S. patents for its handheld neurosurgical robotic platform.

Panda targets neurosurgeons performing complex minimally invasive brain and spine procedures. The system remains in development, with recent financing intended to support clinical translation, regulatory work, and further platform advancement. It is best understood as an early neurosurgical robotics company focused on handheld dexterity enhancement for confined neuroanatomy.

Tools and Infrastructure
Clinical Workflows
Experimental

Neurofounders Insights

Modality:
Others
Form Factor:
Surgical system
Interface Depth:
Other
Indication:
Multi-indication
Target user:
Clinicians
Regulatory stage:
Preclinical

Seed

Panda Surgical sits in early neurosurgical robotics infrastructure, with handheld robotic instruments designed for confined cranial and spinal workflows. Its positioning is differentiated by combining wristed micro-instruments with AI-supported workflow assistance in a surgeon-controlled handheld format.

Related companies

Articles featuring

Panda Surgical

No articles yet!

Press releases

No press releases published yet.